Follow
PharmaLundensis AB
Spotlight (Sweden)
PharmaLundensis is a research company. Main focus is on the treatment of severe pulmonary diseases. The three diseases the company is specialised in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced lung failure. In addition, development is made on system that eliminates the release of pharmaceutical pollution. PharmaLundensis is based in Lund.
Sector:
HEALTH CARE
>
Biotechnology
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
PHAL
SE0003359710
Spotlight
Sweden (SE)
Details of share in PharmaLundensis AB with ticker PHAL
Status
Active
Order book id
4110
Amount of instruments
24 659 026
Par value
0.0500
Market cap
33 300 000.00 SEK
Currency
SEK
First trading date
06 Jul 2010
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
2.25 SEK
25.9M SEK
25 May - 08 Jun 2010
IPO in PharmaLundensis AB
Market
Spotlight
Subscription period
25 May - 08 Jun 2010
Subscription price
Price per share
2.25 SEK
Target to raise
4 837 000 SEK
Types
Pre-money valuation
25 900 000 SEK
Subscription block size
Minimum subscription
2 000
Record date
Offer status
Closed
Listing status
Listed
First trading date
06 Jul 2010
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
5.00 SEK
68.3M SEK
05 Oct - 31 Oct 2011
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
05 Oct - 31 Oct 2011
Subscription price
Price per share
5.00 SEK
Target to raise
5 257 000 SEK
Types
Share issue
Pre-money valuation
68 300 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:13.
Type
Price
Pre-money valuation
Time
Files
New issue
5.00 SEK
70.9M SEK
04 Apr - 20 Apr 2012
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
04 Apr - 20 Apr 2012
Subscription price
Price per share
5.00 SEK
Target to raise
3 000 000 SEK
Types
Share issue
Pre-money valuation
70 900 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Without preferential rights. In case of oversubscription, the Board of Directors shall decide on allotment, whereby each shareholder shall first receive an allocation of an item of 500 shares.
Type
Price
Pre-money valuation
Time
Files
New issue
5.00 SEK
73.9M SEK
10 Sep - 21 Sep 2012
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
10 Sep - 21 Sep 2012
Subscription price
Price per share
5.00 SEK
Target to raise
5 000 000 SEK
Types
Share issue
Pre-money valuation
73 900 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
7.00 SEK
05 Oct - 12 Oct 2012
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
05 Oct - 12 Oct 2012
Subscription price
Price per share
7.00 SEK
Target to raise
2 100 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
12.00 SEK
193M SEK
03 Jun - 19 Jun 2013
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
03 Jun - 19 Jun 2013
Subscription price
Price per share
12.00 SEK
Target to raise
12 000 000 SEK
Types
Share issue
Pre-money valuation
193 000 000 SEK
Subscription block size
Minimum subscription
200
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
12.00 SEK
204M SEK
15 Sep - 03 Oct 2014
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
15 Sep - 03 Oct 2014
Subscription price
Price per share
12.00 SEK
Target to raise
12 000 000 SEK
Types
Share issue
Pre-money valuation
204 000 000 SEK
Subscription block size
Minimum subscription
200
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to the public.
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
105M SEK
28 Sep - 16 Oct 2015
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
28 Sep - 16 Oct 2015
Subscription price
Price per share
6.00 SEK
Target to raise
10 506 000 SEK
Types
Share issue
Pre-money valuation
105 000 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:10. For each share held on the record date, a subscription right is received and ten subscription rights entitle the holder to subscribe for one share.
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
113M SEK
20 Feb - 10 Mar 2017
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
20 Feb - 10 Mar 2017
Subscription price
18.00 SEK
Price per share
6.00 SEK
Target to raise
8 903 000 SEK
Types
Share issue
Pre-money valuation
113 000 000 SEK
Subscription block size
Minimum subscription
100
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 3:38. Thirty-eight (38) held shares in the Company give the right to subscribe for one (1) unit.
Type
Price
Pre-money valuation
Time
Files
New issue
3.50 SEK
70.7M SEK
04 Apr - 18 May 2018
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
04 Apr - 18 May 2018
Subscription price
Price per share
3.50 SEK
Target to raise
10 140 000 SEK
Types
Share issue
Pre-money valuation
70 700 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:7. Each existing PharmaLundensis share entitles the holder to receive one (1) subscription right and seven (7) subscription rights entitle to subscribe for one new share.
Type
Price
Pre-money valuation
Time
Files
New issue
2.50 SEK
50.32M SEK
19 Oct - 02 Nov 2018
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
19 Oct - 02 Nov 2018
Subscription price
10.00 SEK
Price per share
2.50 SEK
Target to raise
10 637 000 SEK
Types
Share issue
Pre-money valuation
50 318 655 SEK
Subscription block size
Minimum subscription
250
Record date
16 Oct 2018
Offer status
Closed
Listing status
Listed
Issue terms
Existing shareholders have preferential rights to subscribe units. For one (1) holding, receives one (1) unit right. Twenty (20) held unit rights in the Company gives the right to subscribe one (1) unit.
Type
Price
Pre-money valuation
Time
Files
New issue
15.00 SEK
15 Apr - 17 May 2019
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
15 Apr - 17 May 2019
Subscription price
Price per share
15.00 SEK
Target to raise
4 732 500 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
One (1) existing share in the Company entitles to one (1) subscription right. Seventy (71) subscription rights entitle to subscribe for one (1) convertible. Subscription price SEK 15 per convertible. Nominal amount: SEK 15. The convertible debenture has an annual interest rate of 13% which is paid in its entirety at the end of May 2025. The owner can call for conversion to shares during the period from April 1, 2025 to April 30, 2025 at a conversion price of SEK 15.
Type
Price
Pre-money valuation
Time
Files
New issue
2.00 SEK
44.8M SEK
17 Jun - 01 Jul 2019
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
17 Jun - 01 Jul 2019
Subscription price
6.00 SEK
Price per share
2.00 SEK
Target to raise
6 109 242 SEK
Types
Share issue
Pre-money valuation
44 801 108 SEK
Subscription block size
Minimum subscription
Record date
13 Jun 2019
Offer status
Closed
Listing status
Listed
Issue terms
For each share held in PharmaLundensis AB held on the record date, one (1) unit right is obtained. Twenty-two (22) unit rights are required to subscribe for one (1) new unit, consisting of three (3) shares and two (2) free subscription warrants.
Type
Price
Pre-money valuation
Time
Files
New issue
2.00 SEK
47.4M SEK
29 Nov - 13 Dec 2019
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
29 Nov - 13 Dec 2019
Subscription price
6.00 SEK
Price per share
2.00 SEK
Target to raise
7 113 888 SEK
Types
Share issue
Pre-money valuation
47 400 000 SEK
Subscription block size
Minimum subscription
250
Record date
26 Nov 2019
Offer status
Closed
Listing status
Listed
Issue terms
Priority 3:20. Each existing share gives the holder one (1) unit right and twenty (20) unit rights entitle to subscribe for one (1) unit. Each unit consists of three (3) shares and two (2) warrants.
Comments for offer & related information
Each subscription option series 2019/2022 II, which is received as part of the unit, entitles the holder to subscribe for one (1) share at a subscription price of SEK 2 per share during the period December 1 - December 31, 2022.
Type
Price
Pre-money valuation
Time
Files
Exercise
5.50 SEK
-
01 Mar - 31 Mar 2020
-
Option exercise terms for WARRANT 2017/2020
Market
Spotlight
Exercise period(s)
01 Mar - 31 Mar 2020
Exercise price
5.50 SEK
Status
Closed
Issue terms
The holder of warrants is entitled to subscribe for each warrants of the 2017/2020 series, one (1) new share. Holders of warrants should note that the subscription price significantly exceeds the current market price (closing price February 21: SEK 1.50). Due to the disadvantageous course, no subscription is issued. Should any holder wish to sign despite this, it is possible to contact the company's office in Lund. Warrants that are not exercised by March 31, 2020 will expire.
Result of offer
Despite the fact that the subscription price far exceeded the current market price, 2,201 shares were subscribed during the subscription period. This results in the issue of 2 201 new shares, which gives a dilution of 0.000089%. New number of shares in the company amounts to 24,661,227. Warrants that have not been used will lapse.
Type
Ticker
ISIN
Market
OPTION
PHAL TO2
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker PHAL TO2
Status
Active
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
-
01 Sep - 30 Sep 2021
-
Option exercise terms for PHAL TO2
Market
Spotlight
Exercise period(s)
01 Sep - 30 Sep 2021
Exercise price
Status
Upcoming
Issue terms
Type
Ticker
ISIN
Market
OPTION
PHAL TO4
SE0013512043
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker PHAL TO4
Status
Active
Order book id
Amount of instruments
2 371 296
Market cap
Currency
SEK
First trading date
Terms
One (1) option entitles the holder to subscribe for one new (1) share.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.00 SEK
-
01 Dec - 31 Dec 2022
-
Option exercise terms for PHAL TO4
Market
Spotlight
Exercise period(s)
01 Dec - 31 Dec 2022
Exercise price
2.00 SEK
Status
Upcoming
Issue terms
One (1) option entitles the holder to subscribe for one new (1) share.
Type
Ticker
ISIN
Market
SHARE
PHAL
SE0003359710
Spotlight
Sweden (SE)
Details of share in PharmaLundensis AB with ticker PHAL
Status
Active
Order book id
4110
Amount of instruments
24 659 026
Par value
0.0500
Market cap
33 300 000.00 SEK
Currency
SEK
First trading date
06 Jul 2010
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
2.25 SEK
25.9M SEK
25 May - 08 Jun 2010
IPO in PharmaLundensis AB
Market
Spotlight
Subscription period
25 May - 08 Jun 2010
Subscription price
Price per share
2.25 SEK
Target to raise
4 837 000 SEK
Types
Pre-money valuation
25 900 000 SEK
Subscription block size
Minimum subscription
2 000
Record date
Offer status
Closed
Listing status
Listed
First trading date
06 Jul 2010
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
5.00 SEK
68.3M SEK
05 Oct - 31 Oct 2011
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
05 Oct - 31 Oct 2011
Subscription price
Price per share
5.00 SEK
Target to raise
5 257 000 SEK
Types
Share issue
Pre-money valuation
68 300 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:13.
Type
Price
Pre-money valuation
Time
Files
New issue
5.00 SEK
70.9M SEK
04 Apr - 20 Apr 2012
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
04 Apr - 20 Apr 2012
Subscription price
Price per share
5.00 SEK
Target to raise
3 000 000 SEK
Types
Share issue
Pre-money valuation
70 900 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Without preferential rights. In case of oversubscription, the Board of Directors shall decide on allotment, whereby each shareholder shall first receive an allocation of an item of 500 shares.
Type
Price
Pre-money valuation
Time
Files
New issue
5.00 SEK
73.9M SEK
10 Sep - 21 Sep 2012
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
10 Sep - 21 Sep 2012
Subscription price
Price per share
5.00 SEK
Target to raise
5 000 000 SEK
Types
Share issue
Pre-money valuation
73 900 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
7.00 SEK
05 Oct - 12 Oct 2012
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
05 Oct - 12 Oct 2012
Subscription price
Price per share
7.00 SEK
Target to raise
2 100 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
12.00 SEK
193M SEK
03 Jun - 19 Jun 2013
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
03 Jun - 19 Jun 2013
Subscription price
Price per share
12.00 SEK
Target to raise
12 000 000 SEK
Types
Share issue
Pre-money valuation
193 000 000 SEK
Subscription block size
Minimum subscription
200
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
Files
New issue
12.00 SEK
204M SEK
15 Sep - 03 Oct 2014
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
15 Sep - 03 Oct 2014
Subscription price
Price per share
12.00 SEK
Target to raise
12 000 000 SEK
Types
Share issue
Pre-money valuation
204 000 000 SEK
Subscription block size
Minimum subscription
200
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to the public.
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
105M SEK
28 Sep - 16 Oct 2015
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
28 Sep - 16 Oct 2015
Subscription price
Price per share
6.00 SEK
Target to raise
10 506 000 SEK
Types
Share issue
Pre-money valuation
105 000 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:10. For each share held on the record date, a subscription right is received and ten subscription rights entitle the holder to subscribe for one share.
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
113M SEK
20 Feb - 10 Mar 2017
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
20 Feb - 10 Mar 2017
Subscription price
18.00 SEK
Price per share
6.00 SEK
Target to raise
8 903 000 SEK
Types
Share issue
Pre-money valuation
113 000 000 SEK
Subscription block size
Minimum subscription
100
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 3:38. Thirty-eight (38) held shares in the Company give the right to subscribe for one (1) unit.
Type
Price
Pre-money valuation
Time
Files
New issue
3.50 SEK
70.7M SEK
04 Apr - 18 May 2018
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
04 Apr - 18 May 2018
Subscription price
Price per share
3.50 SEK
Target to raise
10 140 000 SEK
Types
Share issue
Pre-money valuation
70 700 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:7. Each existing PharmaLundensis share entitles the holder to receive one (1) subscription right and seven (7) subscription rights entitle to subscribe for one new share.
Type
Price
Pre-money valuation
Time
Files
New issue
2.50 SEK
50.32M SEK
19 Oct - 02 Nov 2018
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
19 Oct - 02 Nov 2018
Subscription price
10.00 SEK
Price per share
2.50 SEK
Target to raise
10 637 000 SEK
Types
Share issue
Pre-money valuation
50 318 655 SEK
Subscription block size
Minimum subscription
250
Record date
16 Oct 2018
Offer status
Closed
Listing status
Listed
Issue terms
Existing shareholders have preferential rights to subscribe units. For one (1) holding, receives one (1) unit right. Twenty (20) held unit rights in the Company gives the right to subscribe one (1) unit.
Type
Price
Pre-money valuation
Time
Files
New issue
15.00 SEK
15 Apr - 17 May 2019
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
15 Apr - 17 May 2019
Subscription price
Price per share
15.00 SEK
Target to raise
4 732 500 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
One (1) existing share in the Company entitles to one (1) subscription right. Seventy (71) subscription rights entitle to subscribe for one (1) convertible. Subscription price SEK 15 per convertible. Nominal amount: SEK 15. The convertible debenture has an annual interest rate of 13% which is paid in its entirety at the end of May 2025. The owner can call for conversion to shares during the period from April 1, 2025 to April 30, 2025 at a conversion price of SEK 15.
Type
Price
Pre-money valuation
Time
Files
New issue
2.00 SEK
44.8M SEK
17 Jun - 01 Jul 2019
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
17 Jun - 01 Jul 2019
Subscription price
6.00 SEK
Price per share
2.00 SEK
Target to raise
6 109 242 SEK
Types
Share issue
Pre-money valuation
44 801 108 SEK
Subscription block size
Minimum subscription
Record date
13 Jun 2019
Offer status
Closed
Listing status
Listed
Issue terms
For each share held in PharmaLundensis AB held on the record date, one (1) unit right is obtained. Twenty-two (22) unit rights are required to subscribe for one (1) new unit, consisting of three (3) shares and two (2) free subscription warrants.
Type
Price
Pre-money valuation
Time
Files
New issue
2.00 SEK
47.4M SEK
29 Nov - 13 Dec 2019
Share issue in PharmaLundensis AB
Market
Spotlight
Subscription period
29 Nov - 13 Dec 2019
Subscription price
6.00 SEK
Price per share
2.00 SEK
Target to raise
7 113 888 SEK
Types
Share issue
Pre-money valuation
47 400 000 SEK
Subscription block size
Minimum subscription
250
Record date
26 Nov 2019
Offer status
Closed
Listing status
Listed
Issue terms
Priority 3:20. Each existing share gives the holder one (1) unit right and twenty (20) unit rights entitle to subscribe for one (1) unit. Each unit consists of three (3) shares and two (2) warrants.
Comments for offer & related information
Each subscription option series 2019/2022 II, which is received as part of the unit, entitles the holder to subscribe for one (1) share at a subscription price of SEK 2 per share during the period December 1 - December 31, 2022.
Type
Ticker
ISIN
Market
OPTION
WARRANT 2017/2020
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker WARRANT 2017/2020
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
The holder of warrants is entitled to subscribe for each warrants of the 2017/2020 series, one (1) new share. Holders of warrants should note that the subscription price significantly exceeds the current market price (closing price February 21: SEK 1.50). Due to the disadvantageous course, no subscription is issued. Should any holder wish to sign despite this, it is possible to contact the company's office in Lund. Warrants that are not exercised by March 31, 2020 will expire.
Type
Price
Pre-money valuation
Time
Files
Exercise
5.50 SEK
-
01 Mar - 31 Mar 2020
-
Option exercise terms for WARRANT 2017/2020
Market
Spotlight
Exercise period(s)
01 Mar - 31 Mar 2020
Exercise price
5.50 SEK
Status
Closed
Issue terms
The holder of warrants is entitled to subscribe for each warrants of the 2017/2020 series, one (1) new share. Holders of warrants should note that the subscription price significantly exceeds the current market price (closing price February 21: SEK 1.50). Due to the disadvantageous course, no subscription is issued. Should any holder wish to sign despite this, it is possible to contact the company's office in Lund. Warrants that are not exercised by March 31, 2020 will expire.
Result of offer
Despite the fact that the subscription price far exceeded the current market price, 2,201 shares were subscribed during the subscription period. This results in the issue of 2 201 new shares, which gives a dilution of 0.000089%. New number of shares in the company amounts to 24,661,227. Warrants that have not been used will lapse.
Type
Ticker
ISIN
Market
OPTION
PHAL TO2
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker PHAL TO2
Status
Active
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
-
01 Sep - 30 Sep 2021
-
Option exercise terms for PHAL TO2
Market
Spotlight
Exercise period(s)
01 Sep - 30 Sep 2021
Exercise price
Status
Upcoming
Issue terms
Type
Ticker
ISIN
Market
OPTION
PHAL TO4
SE0013512043
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker PHAL TO4
Status
Active
Order book id
Amount of instruments
2 371 296
Market cap
Currency
SEK
First trading date
Terms
One (1) option entitles the holder to subscribe for one new (1) share.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.00 SEK
-
01 Dec - 31 Dec 2022
-
Option exercise terms for PHAL TO4
Market
Spotlight
Exercise period(s)
01 Dec - 31 Dec 2022
Exercise price
2.00 SEK
Status
Upcoming
Issue terms
One (1) option entitles the holder to subscribe for one new (1) share.
People
Staffan Skogvall
CEO
Linus Sjödahl
Chairman of the board
Ingela Skogvall-Svensson
Board member
Jonas Erjefält
Board member
Staffan Skogvall
Board member
Company Details
Sector
HEALTH CARE

Address
Scheelevägen 2
Zip code
223 63
City/district
Lund
Country
Sweden (SE)
Registration number
556708-8074
LEI code
54930082I88D5N3GQ506
First trade date
06 Jul 2010
Registration date
17 Aug 2016
Short name
PharmaLundensis

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date